Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Cancer Chemotherapy and Pharmacology
|
June 10, 1998
Comparative studies between the effects of mitozolomide and two novel tetrazepinones PYRCL and QUINCL on NIH:OVCAR-3 cells
B J Jean-Claude, A Mustafa, Z Damian, et al.
Drug Metabolism Letters
|
April 10, 2009
Molecular analysis of the in vivo metabolism and biodistribution of metabolically and non-metabolically activated combi-molecules of the triazene class
Qiyu Qiu, Anne-Laure Larroque, Bernard Gibbs, et al.
Biochemical Pharmacology
|
March 13, 1999
Cytokinetics of a novel 1,2,3-triazene-containing heterocycle, 8-nitro-3-methyl-benzo-1,2,3,5-tetrazepin-4(3H)-one (NIME), in the human epithelial ovarian cancer cell line OVCAR-3
B J Jean-Claude, A Mustafa, Z Damian, et al.
European Journal of Medicinal Chemistry
|
July 5, 2011
Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes
Hizbullah Khan, Amin Badshah, Ghulam Murtaz, et al.
Biochemical Pharmacology
|
October 11, 1996
Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate
L Panasci, B J Jean-Claude, D Vasilescu, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
August 25, 2000
Aortic stent-grafts in patients with renal transplants
R Sawhney, T A Chuter, S D Wall, et al.
The Prostate
|
February 1, 2012
"Combi-targeting" mitozolomide: conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer
Youqiang Fang, Qiyu Qiu, Juozas Domarkas, et al.
British Journal of Cancer
|
January 1, 1997
Design and mechanism of action of a novel cytotoxic 1,2,3-triazene-containing heterocycle, 3,5-dimethyl-pyrido-1,2,3,5-tetrazepin-4-one (PYRZ), in the human epithelial ovarian cancer cell line NIH:OVCAR-3 in vitro
B J Jean-Claude, A Mustafa, N D Cetateanu, et al.
European Journal of Medicinal Chemistry
|
March 8, 2020
Comparative analysis of the dual EGFR-DNA targeting and growth inhibitory properties of 6-mono-alkylamino- and 6,6-dialkylaminoquinazoline-based type II combi-molecules
Julie Schmitt, Elliot Goodfellow, Shanlong Huang, et al.
Frontiers in Allergy
|
September 30, 2024
Peanut allergen characterization and allergenicity throughout development
Casey G Cohen, Yael Levy, Diana Toscano-Rivero, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Cancer Chemotherapy and Pharmacology
|
June 10, 1998
Comparative studies between the effects of mitozolomide and two novel tetrazepinones PYRCL and QUINCL on NIH:OVCAR-3 cells
B J Jean-Claude, A Mustafa, Z Damian, et al.
Drug Metabolism Letters
|
April 10, 2009
Molecular analysis of the in vivo metabolism and biodistribution of metabolically and non-metabolically activated combi-molecules of the triazene class
Qiyu Qiu, Anne-Laure Larroque, Bernard Gibbs, et al.
Biochemical Pharmacology
|
March 13, 1999
Cytokinetics of a novel 1,2,3-triazene-containing heterocycle, 8-nitro-3-methyl-benzo-1,2,3,5-tetrazepin-4(3H)-one (NIME), in the human epithelial ovarian cancer cell line OVCAR-3
B J Jean-Claude, A Mustafa, Z Damian, et al.
European Journal of Medicinal Chemistry
|
July 5, 2011
Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes
Hizbullah Khan, Amin Badshah, Ghulam Murtaz, et al.
Biochemical Pharmacology
|
October 11, 1996
Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate
L Panasci, B J Jean-Claude, D Vasilescu, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
|
August 25, 2000
Aortic stent-grafts in patients with renal transplants
R Sawhney, T A Chuter, S D Wall, et al.
The Prostate
|
February 1, 2012
"Combi-targeting" mitozolomide: conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer
Youqiang Fang, Qiyu Qiu, Juozas Domarkas, et al.
British Journal of Cancer
|
January 1, 1997
Design and mechanism of action of a novel cytotoxic 1,2,3-triazene-containing heterocycle, 3,5-dimethyl-pyrido-1,2,3,5-tetrazepin-4-one (PYRZ), in the human epithelial ovarian cancer cell line NIH:OVCAR-3 in vitro
B J Jean-Claude, A Mustafa, N D Cetateanu, et al.
European Journal of Medicinal Chemistry
|
March 8, 2020
Comparative analysis of the dual EGFR-DNA targeting and growth inhibitory properties of 6-mono-alkylamino- and 6,6-dialkylaminoquinazoline-based type II combi-molecules
Julie Schmitt, Elliot Goodfellow, Shanlong Huang, et al.
Frontiers in Allergy
|
September 30, 2024
Peanut allergen characterization and allergenicity throughout development
Casey G Cohen, Yael Levy, Diana Toscano-Rivero, et al.
Page
of 8